Scott E. Schaus

Scott E. Schaus is a Professor of Organic and Medicinal Chemistry at Boston University. He leads the Schaus Group, focusing on enantioselective catalytic methodologies and biomedical research. His work spans development of novel synthetic techniques, including boronate catalysis and asymmetric Mannich reactions, as well as translational science targeting cancer and neglected tropical diseases. Collaborations with the Boston University Center for Molecular Discovery (CMD-BU) drive advancements in chemical library synthesis and drug discovery.

• Education: B.A. in Chemistry (Boston University, 1995; summa cum laude), Ph.D. in Organic Chemistry (Harvard University, 1999)
• Research: Specializes in catalytic asymmetric synthesis, natural product construction, and antiparasitic/anticancer drug development. Notable projects include liver cancer treatments with Prof. Ulla Hansen and work on Chagas disease.

His lab has produced 20 Ph.D. graduates and 3 postdocs since 2001, with alumni in academia, pharmaceutical R&D, and industry.

Current interests include expanding catalytic methodologies and applying chemical synthesis to biomedical challenges. The Schaus Group actively explores small molecule inhibitors, with a focus on LSF transcription factor pathways and antiviral agents.